PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA).
PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, by enabling reliable adhesive joining which is stronger than the composite structures themselves.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 1, 2022 | Series Unknown | €2.35M | 3 | Act Venture Capital | — | Detail |
Jun 24, 2020 | Seed | €1.10M | 2 | Atlantic Bridge University Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Act Venture Capital | Yes | Series Unknown |
Atlantic Bridge University Fund | — | Series Unknown |
Enterprise Ireland | — | Series Unknown |